OSCE stationDrNB Cardiology – Viva master list
Treatment & procedure of choice
The “what is the treatment of choice?” question, answered for 63 congenital and adult conditions. Each entry gives the treatment or procedure of choice, the guideline basis with class of recommendation where one exists, and a DrNB viva pearl.
How to present in the viva: Name the treatment of choice in one line, give the indication (the threshold or trigger that makes it necessary), quote the guideline and class if you know it, and finish with the main alternative and when it would be chosen instead.
ACongenital: shunt lesions
1.Ostium secundum atrial septal defect (ASD)
- Treatment of choice: Percutaneous Transcatheter Device Closure.
- Guideline basis: ESC 2020 ACHD: closure recommended for RV volume overload with PVR <3 WU (Class I); transcatheter closure is the preferred method when anatomy is suitable.
- DrNB pearl: Device closure is preferred when the rims are adequate (about 5 mm or more), except the retro-aortic rim, whose deficiency is common and usually still allows device closure. Very large defects or deficient inferior/posterior rims need surgery.
2.Ostium primum / sinus venosus ASD
- Treatment of choice: Surgical Patch Closure.
- Guideline basis: ESC 2020 ACHD: closure for RV volume overload with PVR <3 WU (Class I); surgery when device closure is unsuitable.
- DrNB pearl: Primum ASD cannot be closed with a device and needs repair of the left AV valve cleft. Sinus venosus ASD needs rerouting of the anomalous right pulmonary veins (patch or Warden procedure); covered-stent transcatheter repair is emerging for selected patients.
3.Patent ductus arteriosus (PDA)
- Treatment of choice: Percutaneous Transcatheter Device Closure (Coils or Amplatzer Duct Occluder).
- Guideline basis: ESC 2020 ACHD: closure for LV volume overload with PVR <3 WU (Class I); device closure is the method of choice when technically suitable.
- DrNB pearl: Closure is indicated for left heart volume overload when PVR is below 3 WU; with PVR ≥5 WU closure is contraindicated (Eisenmenger).
4.Muscular ventricular septal defect (VSD)
- Treatment of choice: Percutaneous Transcatheter Device Closure.
- Guideline basis: ESC 2020 ACHD: closure for LV volume overload with PVR <3 WU (Class I); device closure is an alternative to surgery for suitable (especially muscular or residual) defects.
- DrNB pearl: Muscular VSDs lie away from the conduction system and suit device closure. Perimembranous VSDs are usually closed surgically; transcatheter closure is possible in selected cases but carries a risk of complete heart block.
5.Atrioventricular septal defect (AVSD / endocardial cushion defect)
- Treatment of choice: Complete Primary Surgical Repair (Patch closure of ASD/VSD and creation of two distinct AV valves).
- Guideline basis: Standard paediatric practice (no adult guideline class).
- DrNB pearl: Complete AVSD is usually repaired at 3–6 months of age, before pulmonary vascular disease develops — which happens earlier in Down syndrome.
6.Aortopulmonary (AP) window
- Treatment of choice: Early Surgical Patch Closure.
- Guideline basis: Standard paediatric practice.
- DrNB pearl: Haemodynamically mimics a massive PDA or Truncus Arteriosus. Requires urgent repair in infancy to prevent rapid onset of Eisenmenger syndrome.
7.Patent foramen ovale (PFO) with cryptogenic stroke
- Treatment of choice: Percutaneous Transcatheter PFO Closure.
- Guideline basis: AHA/ASA 2021 secondary stroke prevention: closure is reasonable in patients aged 18–60 with a non-lacunar stroke of undetermined cause and a high-risk PFO (Class IIa); European position paper 2018 similar.
- DrNB pearl: Benefit is greatest with a high RoPE score or high-risk PFO anatomy (large shunt or atrial septal aneurysm). Trials (CLOSE, RESPECT, REDUCE) showed fewer recurrent strokes than antiplatelet therapy alone.
8.Gerbode defect (left ventricle to right atrium shunt)
- Treatment of choice: Surgical Patch Closure (or Transcatheter Device Closure in highly selected anatomies).
- Guideline basis: Standard practice.
- DrNB pearl: A true LV-to-RA shunt occurring through the membranous septum above the tricuspid valve insertion. You must distinguish this clinically from an "indirect" Gerbode (a standard VSD with a jet directed through a cleft/defect in the tricuspid septal leaflet).
9.Lutembacher syndrome
- Treatment of choice: Percutaneous Transvenous Mitral Commissurotomy (PTMC) followed by Transcatheter ASD Device Closure. (If unsuitable for PTMC, surgical double repair).
- Guideline basis: Standard practice.
- DrNB pearl: An ASD with mitral stenosis. The ASD decompresses the left atrium and protects the lungs, but the large left-to-right shunt leads to RV volume overload and failure.
10.Double chambered right ventricle (DCRV)
- Treatment of choice: Surgical Resection of the Anomalous Muscle Bands (+ VSD closure).
- Guideline basis: ESC 2020 ACHD: surgery for a significant mid-ventricular gradient with symptoms or RV dysfunction.
- DrNB pearl: Anomalous hypertrophied muscle bundles divide the Right Ventricle into a high-pressure proximal chamber and a low-pressure distal chamber. It is heavily associated with a perimembranous VSD (which usually dumps blood into the high-pressure proximal chamber).
11.Aorto-left ventricular tunnel (ALVT)
- Treatment of choice: Urgent Surgical Patch Closure of the Aortic Orifice.
- Guideline basis: Standard surgical practice.
- DrNB pearl: An abnormal paravalvular channel connecting the ascending aorta directly to the Left Ventricle, bypassing the aortic valve. It mimics severe, acute aortic regurgitation causing massive neonatal heart failure, but the native aortic valve leaflets are structurally normal.
BCongenital: obstructive lesions
12.Coarctation of the aorta (neonates & infants)
- Treatment of choice: Surgical Resection with Extended End-to-End Anastomosis.
- Guideline basis: Standard paediatric practice.
- DrNB pearl: Stents are generally avoided in neonates because they cannot grow with the child (used only as a bridge in very sick infants); surgical repair is standard.
13.Coarctation of the aorta (adults & adolescents)
- Treatment of choice: Transcatheter stent implantation (bare or covered stent) when technically suitable.
- Guideline basis: ESC 2020 ACHD: repair when the non-invasive gradient is ≥20 mmHg with upper-limb hypertension or significant anatomical narrowing; stenting recommended when technically suitable (Class I).
- DrNB pearl: Stenting has largely replaced surgery in adults and adolescents because of lower morbidity; covered stents reduce the risk of aortic wall injury in complex or tight lesions.
14.Subaortic stenosis (discrete membranous)
- Treatment of choice: Surgical resection of the membrane (with septal myectomy if needed).
- Guideline basis: ESC 2020 ACHD: surgery for symptomatic patients with mean gradient ≥40 mmHg or severe AR (Class I); consider in asymptomatic patients with LV dysfunction, LVH or progressive AR.
- DrNB pearl: Balloon dilatation is ineffective. The high-velocity jet damages the aortic leaflets, so progressive aortic regurgitation is an indication for surgery. Recurrence after resection is common.
15.Supravalvular aortic stenosis (Williams syndrome)
- Treatment of choice: Surgical Patch Aortoplasty (Doty or Brom Procedure).
- Guideline basis: ESC 2020 ACHD: surgery for symptomatic patients with mean gradient ≥40 mmHg (Class I).
- DrNB pearl: Often associated with peripheral pulmonary stenosis. Care must be taken to avoid occluding the coronary ostia during surgical reconstruction.
16.Cor triatriatum sinister
- Treatment of choice: Surgical Excision of the Fibromuscular Membrane.
- Guideline basis: Standard surgical practice.
- DrNB pearl: Mimics mitral stenosis but the mitral leaflets are normal on echo; the membrane lies above the LA appendage. Excision is curative.
17.Shone's complex
- Treatment of choice: Multi-level Surgical Relief (Coarctation repair, resection of subaortic membrane, and supramitral ring resection).
- Guideline basis: Standard surgical practice.
- DrNB pearl: A highly tested congenital constellation consisting of four sequential left-sided obstructive lesions: parachute mitral valve, supramitral ring, subaortic stenosis, and coarctation of the aorta. The entire left-sided axis must be evaluated and treated as a single haemodynamic unit.
18.Congenital mitral stenosis (parachute mitral valve)
- Treatment of choice: Surgical mitral valve repair; replacement only if repair fails or is not possible.
- Guideline basis: Standard surgical practice.
- DrNB pearl: All chordae insert into a single papillary muscle, producing a funnel-shaped stenotic valve. Balloon valvotomy is generally ineffective and risky. Often part of Shone complex.
CCongenital: cyanotic and single-ventricle lesions
19.Tetralogy of Fallot (ToF) — standard infant
- Treatment of choice: Complete Primary Surgical Repair (VSD closure and RVOT relief).
- Guideline basis: Standard paediatric practice.
- DrNB pearl: Elective complete repair is usually performed at 3–6 months (up to about 1 year).
20.Tetralogy of Fallot with pulmonary atresia (ToF-PA)
- Treatment of choice: MAPCA Unifocalization and RV-to-PA Conduit (Rastelli-type repair).
- Guideline basis: Standard paediatric practice.
- DrNB pearl: Major Aortopulmonary Collateral Arteries (MAPCAs) must be surgically gathered (unifocalized) into a single pulmonary confluence before establishing a connection to the Right Ventricle.
21.d-Transposition of the great arteries (D-TGA)
- Treatment of choice: Arterial Switch Operation (Jatene Procedure).
- Guideline basis: Standard paediatric practice.
- DrNB pearl: Ideally performed within the first 2–3 weeks of life, before the LV deconditions against low pulmonary pressure; later, the LV may need retraining (PA banding).
22.Congenitally corrected TGA (L-TGA)
- Treatment of choice: Children: anatomical repair (double switch) in selected patients; adults: tricuspid (systemic AV valve) replacement for severe TR and heart-failure therapy.
- Guideline basis: ESC 2020 ACHD: tricuspid valve replacement for severe systemic AV valve regurgitation with RVEF >40% (Class I).
- DrNB pearl: Double switch restores the LV to the systemic circulation but is done only in children at expert centres, often after LV retraining; it is generally not suitable for adults. Asymptomatic patients are observed.
23.Truncus arteriosus
- Treatment of choice: Early Complete Surgical Repair (VSD closure and RV-to-PA conduit).
- Guideline basis: Standard paediatric practice.
- DrNB pearl: The truncal valve becomes the aortic valve; the pulmonary arteries are detached from the trunk and connected to the RV with a conduit (Rastelli-type repair). Repair is done in the first weeks of life.
24.Total anomalous pulmonary venous connection (TAPVC)
- Treatment of choice: Emergency / Urgent Surgical Re-routing.
- Guideline basis: Standard paediatric practice.
- DrNB pearl: Obstructed TAPVC (commonly the infracardiac variant) is a profound surgical emergency requiring immediate operation, bypassing medical stabilization.
25.Ebstein anomaly
- Treatment of choice: Cone reconstruction of the tricuspid valve.
- Guideline basis: ESC 2020 ACHD: surgical repair for severe TR with symptoms or progressive RV dilatation or dysfunction (Class I).
- DrNB pearl: Cone repair is preferred over valve replacement when feasible: it reconstructs the native leaflets at the true annulus.
26.Pulmonary atresia with intact ventricular septum (PA-IVS) — no sinusoids
- Treatment of choice: Transcatheter Radiofrequency (RF) Perforation and Balloon Valvuloplasty.
- Guideline basis: Standard paediatric practice.
- DrNB pearl: Suitable when the RV is tripartite and adequately sized and there is no RV-dependent coronary circulation; perforation and balloon valvotomy can establish a biventricular circulation.
27.Pulmonary atresia with intact ventricular septum (PA-IVS) — with sinusoids
- Treatment of choice: Single-ventricle palliation (systemic-to-pulmonary shunt, then Glenn and Fontan) or transplantation.
- Guideline basis: Standard paediatric practice.
- DrNB pearl: RV decompression is contraindicated with RV-dependent coronary circulation: it lowers RV pressure, reverses flow in the fistulae and causes myocardial ischaemia or death.
28.Tricuspid atresia
- Treatment of choice: Staged single-ventricle palliation: shunt (or PA band if flow is excessive) in infancy → bidirectional Glenn → Fontan.
- Guideline basis: Standard paediatric practice.
- DrNB pearl: Because the right ventricle is severely hypoplastic, survival strictly depends on an unrestrictive ASD (to empty the right atrium) and a VSD or PDA to perfuse the lungs.
29.Double outlet right ventricle (DORV) — Taussig-Bing variant
- Treatment of choice: Arterial Switch Operation (ASO) plus VSD Closure.
- Guideline basis: Standard paediatric practice.
- DrNB pearl: In this DORV variant, the VSD is strictly subpulmonary. Oxygenated blood from the Left Ventricle preferentially shoots out the pulmonary artery. It haemodynamically mimics D-TGA, which is why an Arterial Switch is the corrective procedure of choice.
DCongenital: coronary, aortic, venous and other anomalies
30.Hypoplastic left heart syndrome (HLHS)
- Treatment of choice: Staged Single Ventricle Palliation (Stage 1: Norwood, Stage 2: Glenn, Stage 3: Fontan).
- Guideline basis: Standard paediatric practice.
- DrNB pearl: The Norwood procedure builds a neo-aorta from the pulmonary trunk and provides pulmonary flow by a modified BT or Sano (RV–PA) shunt. A hybrid stage 1 or transplantation are alternatives.
31.Double outlet right ventricle (DORV) with subaortic VSD
- Treatment of choice: Intraventricular Baffle Repair.
- Guideline basis: Standard paediatric practice.
- DrNB pearl: The surgeon builds a tunnel (baffle) inside the Right Ventricle to route Left Ventricular blood from the VSD directly into the Aorta.
32.ALCAPA (Bland-White-Garland syndrome)
- Treatment of choice: Surgical reimplantation of the left coronary artery into the aorta (Takeuchi repair if reimplantation is not possible).
- Guideline basis: Standard surgical practice.
- DrNB pearl: The anomalous left coronary artery is detached from the low-pressure pulmonary artery and reimplanted into the aorta to restore oxygenated, high-pressure flow to the Left Ventricle.
33.Coronary artery fistula (symptomatic or large)
- Treatment of choice: Transcatheter coil or plug closure (surgical ligation if anatomy is unfavourable).
- Guideline basis: ACC/AHA 2018 ACHD: closure for large fistulae, or small-to-moderate fistulae with symptoms, ischaemia or volume overload.
- DrNB pearl: Preferred over surgery when the anatomy is favourable (a narrow neck and distinct drainage site) and closure will not compromise normal distal coronary branches.
34.Ruptured sinus of Valsalva aneurysm
- Treatment of choice: Urgent Surgical Patch Repair (or Transcatheter Device Closure in selected anatomies).
- Guideline basis: Standard practice.
- DrNB pearl: Usually ruptures into the RV (right coronary sinus) or RA (non-coronary sinus), creating an acute left-to-right shunt with a continuous murmur.
35.Interrupted aortic arch (IAA)
- Treatment of choice: Emergency PGE1 Infusion followed by Single-Stage Surgical Arch Reconstruction and VSD Closure.
- Guideline basis: Standard paediatric practice.
- DrNB pearl: The systemic circulation to the lower body is entirely ductal-dependent. It is highly associated with DiGeorge Syndrome (22q11.2 deletion), mandating irradiated, CMV-negative blood transfusions due to absent thymus/T-cell dysfunction.
36.Anomalous aortic origin of a coronary artery (AAOCA / interarterial course)
- Treatment of choice: Surgical Coronary Unroofing (or Reimplantation).
- Guideline basis: ACC/AHA 2018 ACHD: surgery for anomalous coronary origin with ischaemic symptoms or ischaemia on testing (Class I); anomalous left coronary from the right sinus can be considered for surgery even without symptoms.
- DrNB pearl: Anomalous RCA from the left sinus is more common, but anomalous left coronary from the right sinus carries a higher risk of sudden death. A slit-like ostium and intramural interarterial course are compressed on exertion; unroofing opens the intramural segment.
37.Bicuspid aortic valve (BAV) associated aortopathy
- Treatment of choice: Prophylactic Surgical Ascending Aorta / Root Replacement.
- Guideline basis: ESC 2024 aortic / ACC/AHA 2022 aortic guidelines.
- DrNB pearl: Replace the aorta at 55 mm; at 50 mm with risk factors (family history of dissection, growth ≥3 mm/year, coarctation, uncontrolled hypertension); and at 45 mm or more if the patient is having aortic valve surgery.
38.Pulmonary artery sling (anomalous left PA)
- Treatment of choice: Surgical Reimplantation of the Left PA (Anterior to the Trachea).
- Guideline basis: Standard paediatric practice.
- DrNB pearl: The only vascular ring that passes directly between the trachea and the esophagus, causing severe respiratory distress. It is highly associated with complete tracheal rings, often requiring a simultaneous slide tracheoplasty.
39.Scimitar syndrome (PAPVC variant)
- Treatment of choice: Surgical Baffle (Routing the anomalous vein to the Left Atrium) +/- Right Lung Lobectomy.
- Guideline basis: Standard surgical practice: repair if Qp:Qs >1.5, RV volume overload or recurrent infections.
- DrNB pearl: Partial anomalous drainage of the right lung to the IVC, right lung hypoplasia and systemic arterial supply to the right lower lobe from the descending aorta.
40.Congenital complete heart block (CCHB)
- Treatment of choice: Permanent Epicardial Pacemaker Implantation.
- Guideline basis: ACC/AHA/HRS 2018 and PACES consensus: pacing for symptoms, low ventricular rate (<55 bpm in neonates, <70 bpm with structural heart disease), wide-QRS escape, complex ectopy or ventricular dysfunction (Class I).
- DrNB pearl: Strongly linked to maternal anti-Ro/SSA and anti-La/SSB antibodies (neonatal lupus). Epicardial leads are used in infants because transvenous leads risk venous occlusion and tricuspid damage.
41.Partial anomalous pulmonary venous connection (PAPVC) — non-scimitar
- Treatment of choice: Surgical baffle repair (Warden procedure for high drainage into the SVC).
- Guideline basis: ESC 2020 ACHD: repair for RV volume overload (Qp:Qs >1.5) with PVR <3 WU.
- DrNB pearl: Indicated if Qp:Qs is greater than 1.5. Often associated with a high Sinus Venosus ASD. The surgeon transects the Superior Vena Cava above the anomalous pulmonary veins, reimplants the SVC into the right atrial appendage, and allows the anomalous veins to drain down the SVC stump through the ASD into the Left Atrium.
42.Kawasaki disease with giant coronary aneurysms (≥8 mm)
- Treatment of choice: Coronary artery bypass grafting with arterial (internal mammary) grafts when ischaemia develops.
- Guideline basis: AHA 2017 Kawasaki statement.
- DrNB pearl: Acute Kawasaki disease is treated with IVIG and aspirin; giant aneurysms (≥8 mm or Z-score ≥10) need anticoagulation plus antiplatelet therapy. Surgical revascularisation with arterial grafts is preferred when ischaemia develops; PCI is limited by calcification.
43.Uhl's anomaly (parchment right ventricle)
- Treatment of choice: Cardiac Transplantation (or RV Exclusion/Fontan Pathway).
- Guideline basis: Expert practice (very rare).
- DrNB pearl: Near-complete absence of RV myocardium, leaving endocardium and epicardium in contact. Unlike ARVC, there is no fibro-fatty replacement.
EAdult: ischaemic heart disease
44.Acute STEMI (presentation within 12 hours of symptom onset)
- Treatment of choice: Primary Percutaneous Coronary Intervention (PCI).
- Guideline basis: ESC 2023 ACS: Class I (A).
- DrNB pearl: Aim for wire crossing within 90 minutes of diagnosis (60 minutes if presenting to a PCI centre). If primary PCI cannot be achieved within 120 minutes, give fibrinolysis within 10 minutes of diagnosis (Class I, A) and transfer for angiography.
45.Left main disease (high complexity / SYNTAX score 33 or greater)
- Treatment of choice: Coronary Artery Bypass Grafting (CABG).
- Guideline basis: ESC 2018 myocardial revascularisation / ESC 2024 CCS: CABG Class I (A); PCI not recommended with high SYNTAX score.
- DrNB pearl: CABG gives better long-term outcomes than PCI in complex left main disease, especially with a LIMA-to-LAD graft.
46.Multivessel coronary artery disease with diabetes mellitus
- Treatment of choice: Coronary Artery Bypass Grafting (CABG).
- Guideline basis: ESC 2024 CCS: CABG recommended over PCI (Class I, A).
- DrNB pearl: FREEDOM showed lower death and MI with CABG than PCI in diabetic multivessel disease; the benefit is clearest with intermediate or high SYNTAX scores.
47.Chronic total occlusion (CTO) with refractory angina
- Treatment of choice: CTO-PCI (Antegrade or Retrograde approaches).
- Guideline basis: ESC 2024 CCS: Class IIa (B).
- DrNB pearl: Only indicated for symptom relief if angina persists despite optimal medical therapy, or for a documented large burden of ischaemia (greater than 10 percent of the myocardium). It is no longer routinely recommended strictly to improve LV ejection fraction.
FAdult: valve disease
48.Severe symptomatic aortic stenosis (patients aged 70 years or older)
- Treatment of choice: Transfemoral Transcatheter Aortic Valve Implantation (TAVI).
- Guideline basis: ESC/EACTS 2025 valvular heart disease: Class I (A).
- DrNB pearl: The 2025 ESC/EACTS guidelines lowered the age for TAVI to 70 years (from 75). Transfemoral TAVI is preferred when access and anatomy are suitable; Heart Team decision.
49.Severe symptomatic aortic stenosis (patients aged 60 years or younger)
- Treatment of choice: Surgical aortic valve replacement (SAVR); mechanical prosthesis favoured under 60 years.
- Guideline basis: ESC/EACTS guidelines: SAVR for younger low-risk patients (Class I); mechanical prosthesis should be considered under 60 years for the aortic position (Class IIa).
- DrNB pearl: A mechanical valve avoids structural deterioration but requires lifelong anticoagulation; the choice is a shared decision (e.g., a bioprosthesis if anticoagulation is unwanted or pregnancy is planned).
50.Severe primary (degenerative) mitral regurgitation
- Treatment of choice: Surgical Mitral Valve Repair.
- Guideline basis: ESC/EACTS 2021: repair recommended when durable repair is likely (Class I, B).
- DrNB pearl: Done in a heart valve centre. Repair (resection, artificial chordae, annuloplasty) is preferred to replacement because it preserves the subvalvular apparatus and LV function.
51.Severe secondary (ventricular) mitral regurgitation
- Treatment of choice: Transcatheter Edge-to-Edge Repair (TEER / MitraClip).
- Guideline basis: ESC/EACTS 2021: Class IIa (B).
- DrNB pearl: For patients who remain symptomatic despite optimised GDMT (and CRT if indicated) and meet COAPT-like criteria (disproportionate MR, LVEF 20–50%, LVESD ≤70 mm).
GAdult: heart failure and cardiomyopathy
52.HFrEF with LBBB and QRS duration 150 ms or greater
- Treatment of choice: Cardiac resynchronisation therapy (CRT-P or CRT-D).
- Guideline basis: ESC 2021 HF: CRT Class I (A); choose CRT-D or CRT-P by ICD indication and patient factors.
- DrNB pearl: Requires LVEF ≤35% and symptoms despite at least 3 months of optimal GDMT. CRT reverses LV remodelling by correcting dyssynchrony.
53.Advanced refractory heart failure (INTERMACS profile 2-4)
- Treatment of choice: Left Ventricular Assist Device (LVAD) Implantation.
- Guideline basis: ESC 2021 HF: Class IIa (B).
- DrNB pearl: Used as bridge to transplant or destination therapy. Fully magnetically levitated centrifugal pumps (HeartMate 3) have markedly reduced pump thrombosis.
54.Hypertrophic obstructive cardiomyopathy (HOCM) with severe symptoms
- Treatment of choice: Surgical Septal Myectomy (Morrow Procedure).
- Guideline basis: ESC 2023 cardiomyopathy: septal reduction therapy Class I (B) in experienced centres.
- DrNB pearl: Indicated when the resting or provoked LVOT gradient is ≥50 mmHg with NYHA III–IV symptoms despite maximum tolerated therapy (beta-blocker, verapamil, mavacamten). Myectomy is preferred with extreme septal thickness (>30 mm) or when other cardiac surgery (mitral, papillary muscle) is needed.
55.Transthyretin cardiac amyloidosis (ATTR-CM) — wild type or hereditary
- Treatment of choice: Tafamidis (Transthyretin Stabiliser).
- Guideline basis: ESC 2021/2023 HF: Class I (B) for NYHA I–II.
- DrNB pearl: Tafamidis stabilises the TTR tetramer and reduces mortality and CV hospitalisation (ATTR-ACT included NYHA I–III); it does not remove existing deposits. Acoramidis is a newer stabiliser.
HAdult: electrophysiology and devices
56.Symptomatic paroxysmal atrial fibrillation (drug refractory)
- Treatment of choice: Pulmonary Vein Isolation (Catheter Ablation).
- Guideline basis: ESC 2024 AF: Class I (A); also a first-line option for paroxysmal AF.
- DrNB pearl: Pulsed field ablation joins radiofrequency and cryoablation; it is largely tissue-selective, reducing oesophageal and phrenic nerve injury.
57.Symptomatic bradycardia (sinus node dysfunction)
- Treatment of choice: Dual-Chamber (DDD) Permanent Pacemaker.
- Guideline basis: ESC 2021 pacing: dual-chamber pacing recommended (Class I, A).
- DrNB pearl: Dual-chamber pacing preserves AV synchrony and reduces AF and pacemaker syndrome compared with VVI pacing.
58.Ventricular tachycardia in structural heart disease (ischaemic scar)
- Treatment of choice: Endocardial Catheter Ablation.
- Guideline basis: ESC 2022 VA/SCD: Class I (B) for recurrent symptomatic monomorphic VT despite amiodarone.
- DrNB pearl: Ablation targets slow-conducting channels in the scar border zone (VANISH trial).
59.Primary prevention of sudden cardiac death (ischaemic cardiomyopathy)
- Treatment of choice: Implantable Cardioverter-Defibrillator (ICD).
- Guideline basis: ESC 2022 VA/SCD: Class I (A).
- DrNB pearl: LVEF ≤35% with NYHA II–III despite ≥3 months of optimal therapy, at least 40 days after MI and 90 days after revascularisation, with expected survival >1 year in good functional status.
IAdult: aortic, pericardial and carotid disease
60.Acute type A aortic dissection
- Treatment of choice: Emergency Open Surgical Aortic Replacement.
- Guideline basis: ESC 2024 aortic guidelines: emergency surgery Class I (B).
- DrNB pearl: Mortality increases by 1 to 2 percent per hour if left untreated. Requires urgent sternotomy, cardiopulmonary bypass (often with deep hypothermic circulatory arrest), and graft replacement of the ascending aorta, with or without aortic valve resuspension.
61.Complicated type B aortic dissection
- Treatment of choice: Thoracic Endovascular Aortic Repair (TEVAR).
- Guideline basis: ESC 2024 aortic guidelines: Class I.
- DrNB pearl: "Complicated" is strictly defined as rapid aortic expansion, impending rupture, uncontrollable hypertension, or end-organ malperfusion syndrome (renal, mesenteric, or spinal ischaemia). TEVAR acts to seal the primary entry tear, depressurizing the false lumen.
62.Chronic constrictive pericarditis
- Treatment of choice: Complete (radical) surgical pericardiectomy.
- Guideline basis: ESC 2015 pericardial: Class I (C) for chronic permanent constriction.
- DrNB pearl: Transient constriction may resolve with anti-inflammatory therapy, so try that first when there is active inflammation. Radical pericardiectomy (phrenic to phrenic) is needed for chronic constriction.
63.Severe symptomatic carotid artery stenosis (70 to 99 percent)
- Treatment of choice: Carotid Endarterectomy (CEA).
- Guideline basis: ESC 2017 PAD / ESVS 2023: Class I (A).
- DrNB pearl: Best done within 14 days of the event. CEA has lower peri-procedural stroke risk than stenting in patients over 70; stenting is an alternative for high cervical lesions, prior neck radiation or high surgical risk.
Classes and cut-offs follow the ESC 2020–2024 and ACC/AHA guidelines current in October 2026; always apply your own institution's protocols.
meritmedscript.comDr. Sidhartha Mullapudi
